Our Opinion

VistaGen Therapeutics is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their pharmaceutical products.

Company Description

VistaGen Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing medicines for depression and other central nervous system (CNS) disorders. Their lead CNS product candidate, AV-101, is an orally available prodrug in Phase 2 development, initially for the adjunctive treatment of major depressive disorder (MDD) in patients with inadequate response to standard FDA-approved antidepressants.